Roger D Dansey Inovio Pharmaceuticals, Inc. (INO) insider trading activity

INO Quotes by TradingView

Roger D Dansey is Director of INOVIO PHARMACEUTICALS, INC.. Currently has a direct ownership of 6,749 shares of INO, which is worth approximately $58,108. The most recent transaction as insider was on May 15, 2024, when has been sold 2,166 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.75K
84.3% 3M change
84.3% 12M change
Total Value Held $58,108

ROGER D DANSEY Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 15 2024
BUY
Exercise of conversion of derivative security
-
2,166 Added 24.3%
6,749 Common Stock
May 13 2024
BUY
Exercise of conversion of derivative security
-
1,000 Added 17.91%
4,583 Common Stock
May 16 2023
BUY
Exercise of conversion of derivative security
-
19,000 Added 30.65%
43,000 Common Stock
May 13 2023
BUY
Exercise of conversion of derivative security
-
12,000 Added 33.33%
24,000 Common Stock
May 13 2022
BUY
Exercise of conversion of derivative security
-
12,000 Added 50.0%
12,000 Common Stock

Also insider at

SGEN
Seagen Inc. Healthcare
President, R&D & CMO
KRON
Kronos Bio, Inc. Healthcare
RDD

Roger D Dansey

Director
Bothell, WA

Track Institutional and Insider Activities on INO

Follow INOVIO PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INO shares.

Notify only if

Insider Trading

Get notified when an Inovio Pharmaceuticals, Inc. insider buys or sells INO shares.

Notify only if

News

Receive news related to INOVIO PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INO